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Abstract 
Patients palliated with Fontan circulation who require mechanical circulatory 
support pose anatomic and physiologic challenges. We treated an acutely failed 
Fontan patient with sequential temporary and durable support devices.  Aspects 
of treatment with each device required modification based on the patient’s 
anatomy and physiology.  
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Patient Profile 
 
A 32-year-old man with Damus-Kaye-Stansel reconstruction and Fontan 
palliation for double inlet left ventricle and L-transposition suffered cardiac arrest 
and gross aspiration.  Bystander CPR was initiated with return of spontaneous 
circulation after 30 minutes.  On arrival to the hospital he was intubated and 
found to be neurologically intact, in cardiogenic shock, anuric, and requiring 
multiple vasoactive infusions.  Creatinine was 3.7 mg/dL, international 
normalized ratio was 1.6, and total bilirubin level was 3.2 mg/dL.  
Echocardiogram showed moderate ventricular dysfunction and mild-moderate 
neo-aortic insufficiency (neo-AI).  Catheterization revealed unobstructed Fontan  
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circuit with pressures = 23mmHg (catheterization 6 months earlier = 16mmHg).  
INTERMACS classification was one. 
 
An Impella 5.0 (Abiomed, Danvers, MA) ventricular assist device (VAD) was 
placed via right axillary cutdown.  Impella passage into the left ventricle, through 
the native pulmonary valve resulted in severe neo-AI.  Repositioning through the 
native aortic valve, into the rudimentary right ventricular outflow chamber, 
allowed full flow and stabilization.  Persistent hemolysis and mucosal bleeding 
prompted Impella removal and HeartWare HVAD® (HeartWare, Framingham, 
MA) placement 10 days later as attempts at Impella weaning caused 
hemodynamic embarrassment.  The long-term goal for the patient was HVAD as 
bridge to transplant.  
 
The HVAD was placed in a hybrid OR via left anterior thoracotomy and left 
axillary cutdown without bypass.  Epicardial ultrasound guided cannula position.  
Left pleural adhesions and chest-wall to pulmonary collaterals mandated 
subcutaneous outflow graft placement. The distal axillary artery was banded to 
prevent unilateral hyperemia. Endovascular semilunar valve closure was 
attempted with a 30mm Amplatzer ventricular septal defect occluder in an 
attempt to minimize neo-AI. It was thought this device would sit nicely within the 
sinus segment of the neo-aortic valve.  Deployment of the device caused 
hemodynamic collapse due to coronary compression, which was relieved with re-
sheathing and removal of the device. 
  
We think the coronary compression was related to over-sizing, but a size 28mm 
device did not have adequate leaflet capture to ensure positional stability. Due to 
hemodynamic instability, it was not possible to ascertain whether the device 
occluded a coronary os directly or by means of distortion/torsion. 
 
The patient made a slow recovery marked by dialysis dependence, extreme 
deconditioning, and nosocomial pneumonias before dying on POD 273.  There 
were some bright spots during his prolonged hospitalization, as he remained 
neurologically intact and enjoyed some quality of life given his ability to eat and 
mobilize via a wheelchair.  He was also able to take a day trip to a major league 
baseball game.  
 
Comment 
 
Since the Fontan circulation is susceptible to failure at multiple levels, a single 
approach to Fontan failure patients is unrealistic and mechanical therapies must 
be individualized.  Impella for single ventricle support as a bridge to Berlin Heart 
(Berlin Heart Inc., The Woodlands, TX)1  in a pediatric patient has been reported, 
but use in adult Fontan circulation has not.  
 
Determining the physiologic cause of Fontan failure is imperative. Fontan 
obstruction or elevated pulmonary vascular resistance (PVR) are not remedied 
with ventricular assist therapies.2   In this case, failure was caused by combined 
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acute decline in ventricular function and aspiration causing elevated PVR.  Such 
patients are typically supported with veno-arterial extracorporeal membrane 
oxygenation (VA-ECMO).  This patient was not a good VA-ECMO candidate 
given the degree of neo-AI.  
 
This patient presented anatomic challenges.  Impella placement into the left 
ventricle, across the patient’s neo-aortic valve resulted in unacceptable neo-AI, 
whereas placement into the rudimentary right ventricle (across the native aortic 
valve) allowed full flow and adequate support (Figure 1).  We elected to place the 
HVAD via a non-sternotomy approach given the overall clinical situation and 
ongoing failure of multiple organ systems.  The LV apex was accessible by left 
anterior thoracotomy. Epicardial and transesophageal echocardiography guided 
precise cannula placement.3   Left pleural symphysis and chest wall to pulmonary 
collaterals mandated extra-thoracic outflow graft placement.  Outflow graft 
placement inside ring reinforced polytetrafluoroethylene prevented kinking or 
stenosis (Figure 2).  Coronary anatomy prevented minimization of neo-AI by 
endovascular closure device. 
 
 
 
Figure 1.  Echocardiogram image shows Impella device in rudimentary right 
ventricular outflow chamber with tip of device near the bulboventricular foramen 
(BVF).  
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Figure 2. Post-operative CT scan of the chest showing VAD in cardiac apex and 
extra-thoracic course of outflow graft.   
 
The optimal management of acute Fontan circulation failure is unknown.  We had 
technical success employing a temporary, intravascular axial flow ventricular 
assist device as a bridge to durable VAD.  Congenital anatomy presents unique 
challenges in caring for these patients and requires flexibility and adaptability 
when using devices designed for normal anatomy.  
 
Ultimate success was not achieved in this case.  However, the experience with 
this patient remains valuable to the still nascent literature regarding mechanical 
support of this disease state.  Fontan circulation patients represent the fastest 
growing population of adults with congenital heart disease and this scenario will 
be confronted with increased frequency in the foreseeable future.4   Some of the 
technical challenges related to this patient’s anatomy are unique to patients with 
congenital disease and worth noting for treating future patients.  The value of a 
multi-disciplinary team of surgeons, interventionalists, and cardiologists with 
expertise in adult congenital heart disease as well as a dedicated cardiothoracic 
ICU cannot be overemphasized in the care of these patients.  
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